ATR Interacting Protein (ATRIP) Peptide
ATRIP
Reactivité: Humain, Souris, Rat
Hôte: Synthetic
BP
-
- Antigène Tous les produits ATRIP
- ATRIP (ATR Interacting Protein (ATRIP))
- Origine
- Humain, Souris, Rat
- Source
- Synthetic
- Application
- Blocking Peptide (BP)
- Attributs du produit
- The peptide is used to block Anti-ATRIP Antibody reactivity.
-
- Indications d'application
- Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Stock
- -20 °C
- Stockage commentaire
- Shipped at 4°C. Store at -20°C for one year.
- Date de péremption
- 12 months
-
- Antigène
- ATRIP (ATR Interacting Protein (ATRIP))
- Synonymes
- 6620401K05Rik Peptide, TREX1 Peptide, Xatrip Peptide, trex1 Peptide, si:dkey-42i9.5 Peptide, ATRIP Peptide, CG7347 Peptide, Dmel\\CG7347 Peptide, Mus304 Peptide, anon-WO0140519.82 Peptide, atrip Peptide, mus(3)304 Peptide, mus-304 Peptide, ATR interacting protein Peptide, ATR interacting protein S homeolog Peptide, mutagen-sensitive 304 Peptide, ATRIP, ATR checkpoint kinase regulatory subunit Rad26 Peptide, ATRIP Peptide, Atrip Peptide, atrip.S Peptide, atrip Peptide, mus304 Peptide, rad26 Peptide
- Sujet
- AGS1, ATR-interacting protein, ATM and Rad3-related-interacting protein
- ID gène
- 84126, 235610
- UniProt
- Q8WXE1, Q8BMG1
-
Vous êtes ici:
